Tejpat (Cinnamomum tamala): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Tejpat work in the body?

Tejpat (Cinnamomum tamala) exerts its effects through bioactive compounds including eugenol, linalool, and methyl cinnamate. Eugenol provides anti-inflammatory and analgesic properties, which may explain traditional use for joint pain. The herb's flavonoids and tannins contribute antioxidant activity. For blood sugar management, preliminary research suggests possible effects on glucose metabolism and insulin sensitivity, though mechanisms are not fully established (Evidence Level C). The volatile oils also act as carminatives, stimulating digestive enzymes and relieving gastrointestinal discomfort through smooth muscle relaxation.

Does Tejpat interact with diabetes or blood thinning medications?

Tejpat may interact with diabetes medications by enhancing glucose-lowering effects, potentially causing hypoglycemia when combined with antidiabetic drugs. The eugenol content may have mild blood-thinning properties, so caution is advised with anticoagulant or antiplatelet medications (Evidence Level C). Those on diabetes medications should monitor blood glucose levels closely and consult a healthcare provider before using medicinal doses. Always inform your healthcare provider about all herbal supplements to prevent adverse interactions.

What is the recommended dosage for Tejpat?

The typical adult dosage for Tejpat depends on the preparation. Fresh or dried leaves can be used liberally in cooking daily. For medicinal purposes, powdered leaf is commonly taken at 1-2 grams daily. Tejpat leaf tea can be consumed at 1-2 cups per day. These recommendations are based on traditional Ayurvedic practice and limited clinical evidence (Evidence Level C). Start with lower doses and increase gradually. Consult a qualified healthcare practitioner for personalized dosing guidance.

Is Tejpat safe during pregnancy?

Tejpat is considered safe during pregnancy when consumed in normal culinary amounts as a food seasoning (Evidence Level C). However, large medicinal doses should be avoided during pregnancy due to insufficient safety data. The herb has a long history of traditional use in South Asian cooking without reported adverse effects. Pregnant women should consult their healthcare provider before using concentrated Tejpat supplements or extracts. Those with allergies to plants in the Lauraceae family should avoid Tejpat entirely.

What are the health benefits of Tejpat leaves?

Tejpat leaves are traditionally used for digestive complaints including bloating, indigestion, and appetite stimulation due to their carminative properties. In Ayurveda, the herb is employed for blood sugar management in diabetes, reducing joint inflammation and pain, and supporting respiratory health (Evidence Level C). The leaves contain antioxidant compounds that may help protect against cellular damage. While these traditional uses have historical precedent, more rigorous clinical studies are needed to confirm efficacy for specific health conditions.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Tejpat (Cinnamomum tamala), also known as Indian bay leaf, is a plant used in culinary and medicinal applications, demonstrating antioxidant, antidiabetic, and antimicrobial properties [PMID:38737243, 39075867, 10548758].

Background

Cinnamomum tamala (Family: Lauraceae) is an economically important tree native to South Asia, commonly referred to as 'Indian bay leaf' or 'Tejpat' [PMID:38737243, 41992462]. It is widely utilized in the food, cosmetic, and pharmaceutical industries [PMID:38737243].

Traditional uses

Traditionally used in Ayurvedic and Yunani medicine for treating toothache, diarrhea, gastrointestinal disorders, vomiting, fever, diabetes, hyperlipidemia, and as a carminative, anthelmintic, and diuretic [PMID:40300760, 20083180, 24236996].

Active compounds

Major components include eugenol (74.79-95.12% in some essential oils) [PMID:39075867, 22424088], E-cinnamyl acetate, E-cinnamaldehyde, and linalool [PMID:37533252]. Other identified bioactive compounds include coumarin, cinnamyl alcohol, cinnamic acid, cinnamyl acetate, catechin, and apigenin [PMID:38737243, 41547255].

Mechanism of action

The herb exhibits antioxidant activity by scavenging DPPH, ABTS, superoxide, and hydroxyl radicals [PMID:39075867, 32180127, 17907743]. It demonstrates antidiabetic potential through the inhibition of α-amylase and α-glucosidase [PMID:39075867]. In inflammation, it targets hub genes such as JUN, P53, IL6, MAPK3, HIF1A, and CASP3, involving apoptosis and MAPK signaling pathways [PMID:38533033, 39171467]. It also shows spasmolytic potential in the rat ileum, likely through a synergistic effect of its components [PMID:33872476].

Clinical evidence

Evidence BMuscle strength and endurance

A proprietary blend of Cinnamomum tamala leaf and Garcinia mangostana fruit rind enhanced muscle strength and endurance in resistance-trained males [PMID:30348185]

Evidence BSkin rejuvenation

A 4% Cinnamomum tamala extract emulgel was evaluated for effects on melanin, erythema, sebum, and facial pores in healthy female volunteers [PMID:31680410]

Evidence DDiabetes

Ethanolic leaf extract significantly lowered blood glucose levels and improved lipid profiles in streptozotocin-induced diabetic rats [PMID:22022005]

Evidence DProstate enlargement

Tamala reduced prostatic enlargement and improved hyperplastic changes in testosterone-induced rats [PMID:24761116]

Evidence DGastric ulcers

Leaf extract significantly reduced the lesion index in ethanol, cold-restraint stress, and pylorus ligation-induced ulcer models in rats [PMID:20083180]

Evidence DHepatotoxicity

Safety & adverse effects

A proprietary blend of Garcinia mangostana and Cinnamomum tamala (CinDura) showed a median lethal dose (LD50) of at least 2000 mg/kg in Wistar rats and was non-irritant to skin and eyes in rabbits [PMID:32802054].

Evidence summary

The evidence consists primarily of in vitro studies and animal models (Level D), with limited clinical trials (Level B) focusing on sports performance and cosmeceuticals. Strong preclinical evidence supports its antioxidant and antidiabetic properties.

PubMed sources

1.PMID: 39075867 (2024) — Antidiabetic and Antioxidant Activities of Indian Bay Leaf (Cinnamomum tamala (Buch.-Ham.) T. Nees & Eberm.) Essential Oils Collected from Meghalaya. · Chemistry & biodiversity
2.PMID: 38737243 (2024) — Chemical fingerprinting and multicomponent quantitative analysis for quality control of Cinnamomum tamala collected from Western Himalaya by HPLC-DAD. · Heliyon
3.PMID: 10548758 (1999) — Antimicrobial screening of some Indian spices. · Phytotherapy research : PTR
4.PMID: 41992462 (2026) — In vivo Anticancer Efficacy of Cinnamomum tamala Leaf Extract in Ehrlich's Carcinoma-Bearing BALB/c Mice. · Recent patents on biotechnology
5.PMID: 41051457 (2025) — α-glucosidase inhibitory potential of endophytic Colletotrichum fructicola of Cinnamomum tamala.

Tejpat

Sources & Citations

Calculate a safe dose of Tejpat